BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20240328T100455Z
UID:b71645cd-6804-40cd-90e9-fcaca62e692f
DTSTART:20220426T090000
DTEND:20220428T160000
CLASS:PRIVATE
DESCRIPTION:
\n
\nFcRn\, Fc&gamm
a\;\, and IgG studies have been propelled by drug developers recently afte
r Argenx&rsquo\;s potential FDA&rsquo\;s approval of first-in-class FcRn a
ntagonist efgartigimod\, AstraZeneca-Alexion&rsquo\;s $39 billion deal\, a
nd positive clinical updates from UCB&rsquo\;s Rozanolixizumab. Successful
modulation of the Fc pathways and optimized IgG antibodies have proven cl
inical utility and demonstrate significant therapeutic potential with more
players poised to bring their candidates through clinic.
\n
\nT
he 2nd Fc Receptor &\; IgG Targeted Therapies Summit is the only dedica
ted meeting to bring you the most up-to-date with clinical and commercial
developments on pioneering strategies to harness the full potential of FcR
s.
\n
\nThis 3-day summit will return in 2022 with a fresh speak
er line-up\, 2 dedicated streams to offer you the A-Z of Fc receptors and
IgG targeting. Bringing together exclusive data on targeting FcRn and FcyR
s\, and the engineering strategies employed to harness the FcR-IgG interac
tion to yield clinical efficacy. Hear from industry leaders such as FDA\,
Genentech\, Alexion\, UCB\, Argenx\, Genmab\, and more as they modulate th
e dynamic behavior of IgG to fast-track candidates to address unmet medica
l needs.
\n
\nJoin 130+ experts in Boston to:
\n- Discuss t
ranslating novel Fc biology insights to innovative drug design
\n- Ex
plore FcR antagonists\, Fc fusion proteins\, and novel antibodies
\n-
Move confidently to clinic with predictive PKPD assessments from best-in-
class cellular assays
\n- Enhance the therapeutic potential of antibo
dies with next-gen engineering strategies to minimize immunogenicity
\n
\nTickets \; \;  \;https://go.evvnt.com/972245-1?pid=1052
\nBrochure <
a href="https://go.evvnt.com/972245-3?pid=1052">https://go.evvnt.com/97224
5-3?pid=1052
\n
\nPrices:
\nConference
+ 2 Workshops - Pharma Biotech USD 3897.00
\nConference Only - Pharm
a Biotech USD 2999.00
\nConference + 2 Workshops - Service provider U
SD 4697.00
\nConference Only - Service provider USD 3599.00
\n\nCategory: Conferences | Science\, Health &\; Med
icine | Pharmaceuticals | Drug Development
SUMMARY:2nd Fc Receptor & IgG Targeted Therapies Summit
BEGIN:VALARM
ACTION:DISPLAY
TRIGGER:-PT1H
SUMMARY:2nd Fc Receptor & IgG Targeted Therapies Summit
END:VALARM
END:VEVENT
END:VCALENDAR